CLINICAL_TRIALS
trial_result
· 2014-07-01
Clinical Trial Update: Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma [Phase 2]
Summary
Phase 2 trial evaluating the bronchoprotective efficacy and safety of orally inhaled BI 1744 CL in patients with intermittent asthma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-07-01